English
FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements
Overview of attention for article published in Oncologist, August 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Mentioned by
- policy
- 1 policy source
- 3 X users
- wikipedia
- 2 Wikipedia pages
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 220 Mendeley